ClinicalTrials.Veeva

Menu

Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease

NYU Langone Health logo

NYU Langone Health

Status

Enrolling

Conditions

Ischemic Heart Disease

Treatments

Procedure: GeriKit Mobile Application

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05788666
22-00841

Details and patient eligibility

About

This study seeks to expand the use of the NYU GeriKit mobile application ("app") in a diverse range of settings to better phenotype older patients, which will enhance both research and patient care.

Full description

This is a single-center proof of concept study of geriatric impairments and feasibility metrics through the use of the GeriKit software application in older adults with ischemic heart disease at the NYU Langone Medical Center. The GeriKit mobile application was developed to make geriatric assessment instruments easily accessible to clinicians who do not have subspecialty training in geriatrics. The GeriKit app has been used clinically but is untested in research settings.

Enrollment

150 estimated patients

Sex

All

Ages

75 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age ≥ 75
  2. Currently hospitalized for acute mycardial infarction (AMI), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG); or hospitalized for AMI, PCI, or CABG within the prior 4 weeks
  3. Capable of self-consent
  4. Understand and are able to perform study procedures in English

Exclusion criteria

  1. Non-ambulatory
  2. Moderate or severe cognitive impairment (operationalized as known diagnosis of dementia)
  3. Unable or unwilling to consent
  4. Incarcerated
  5. Unable to use complete assessments in English
  6. Unable to complete geriatric assessment for other reasons

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

150 participants in 1 patient group

Geriatric Assessments using GeriKit App
Experimental group
Description:
Participants will receive comprehensive geriatric assessment via GeriKit app at baseline. All participants will complete a follow-up assessment via phone at 6 months. 20 of the 150 enrolled participants will continue onto a qualitative questionnaire after the completion of the 6-month follow up call.
Treatment:
Procedure: GeriKit Mobile Application

Trial contacts and locations

1

Loading...

Central trial contact

John A. Dodson, MD, MPH, FACC; Victoria Rosado Santiago

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems